Transcripts

Ginkgo Bioworks Holdings (DNA) earnings call transcripts

Every Ginkgo Bioworks Holdings, Inc. earnings call Gloomberb has transcribed, with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed 2026 as a shift from restructuring toward autonomous-lab investment, using Nebula and academic deployments to prove scalability.

    Aug 05, 2026Mildly positive0.20